Insulet Corporation

BOVESPA:P2OD34 Stock Report

Market Cap: R$117.7b

Insulet Management

Management criteria checks 3/4

Insulet's CEO is Jim Hollingshead, appointed in Jun 2022, has a tenure of 2.5 years. total yearly compensation is $12.38M, comprised of 6.8% salary and 93.2% bonuses, including company stock and options. directly owns 0.025% of the company’s shares, worth R$29.34M. The average tenure of the management team and the board of directors is 2 years and 4.1 years respectively.

Key information

Jim Hollingshead

Chief executive officer

US$12.4m

Total compensation

CEO salary percentage6.8%
CEO tenure2.5yrs
CEO ownership0.02%
Management average tenure2yrs
Board average tenure4.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Jim Hollingshead's remuneration changed compared to Insulet's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$421m

Jun 30 2024n/an/a

US$395m

Mar 31 2024n/an/a

US$234m

Dec 31 2023US$12mUS$842k

US$206m

Sep 30 2023n/an/a

US$120m

Jun 30 2023n/an/a

US$63m

Mar 31 2023n/an/a

US$600k

Dec 31 2022US$11mUS$440k

US$5m

Sep 30 2022n/an/a

US$17m

Jun 30 2022n/an/a

US$35m

Mar 31 2022n/an/a

US$45m

Dec 31 2021US$290kn/a

US$17m

Sep 30 2021n/an/a

-US$29m

Jun 30 2021n/an/a

-US$30m

Mar 31 2021n/an/a

US$9m

Dec 31 2020US$259kn/a

US$7m

Sep 30 2020n/an/a

US$29m

Jun 30 2020n/an/a

US$18m

Mar 31 2020n/an/a

US$5m

Dec 31 2019US$261kn/a

US$12m

Compensation vs Market: Jim's total compensation ($USD12.38M) is above average for companies of similar size in the BR market ($USD5.73M).

Compensation vs Earnings: Jim's compensation has been consistent with company performance over the past year.

CEO

Jim Hollingshead (61 yo)

2.5yrs

Tenure

US$12,379,765

Compensation

Dr. James R. Hollingshead, also known as Jim, Ph.D. had been President of Sleep & Respiratory Care Business at ResMed Inc. since July 2020 until May 05, 2022 and served as its President of Sleep Business s...

Leadership Team

NamePositionTenureCompensationOwnership
James Hollingshead
President2.5yrsUS$12.38m0.025%
R$ 29.3m
Lauren Budden
Group VP5.7yrsUS$1.44m0.0049%
R$ 5.7m
Mark Field
Senior VP & CTO1.4yrsUS$2.37m0.014%
R$ 16.4m
John Kapples
Senior VP & General Counsel5.8yrsUS$2.47m0.021%
R$ 25.2m
Eric Benjamin
Executive VP6.8yrsUS$3.14m0.018%
R$ 21.2m
Ana Chadwick
Executive VPless than a yearno data0.00014%
R$ 164.8k
Prem Singh
Senior Vice President of Global Operations1.9yrsno data0.0052%
R$ 6.1m
June Lazaroff
Senior Director of Investor Relationsless than a yearno datano data
Laetitia Cousin
Senior VP of Regulatory Affairs2yrsno data0.0044%
R$ 5.2m
Angela Wiczek
Senior Director of Corporate Communicationsno datano datano data
Philip Hildale
Senior Vice President of Sales & Customer Care9.9yrsno datano data
Andrew Isaacson
Senior VP of Strategy & Corporate Developmentless than a yearno datano data

2.0yrs

Average Tenure

50.5yo

Average Age

Experienced Management: P2OD34's management team is considered experienced (2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
James Hollingshead
President5.4yrsUS$12.38m0.025%
R$ 29.3m
Elizabeth Weatherman
Independent Director2.8yrsUS$322.50k0.0040%
R$ 4.7m
Timothy Scannell
Independent Chairman10.3yrsUS$387.10k0.042%
R$ 49.0m
Robert Sherwin
Chairman of Scientific Advisory Boardno datano datano data
Howard Wolpert
Member of Scientific Advisory Boardno datano datano data
Margaret Lawlor
Member of Educator Advisory Boardno datano datano data
Camille Izlar
Member of Educator Advisory Boardno datano datano data
Mary Halvorson
Member of Educator Advisory Boardno datano datano data
Steven Edelman
Member of Scientific Advisory Boardno datano datano data
Anne Daly
Member of Educator Advisory Boardno datano datano data
John Buse
Member of Scientific Advisory Boardno datano datano data
Timothy Stonesifer
Independent Directorless than a yearno datano data

4.1yrs

Average Tenure

61yo

Average Age

Experienced Board: P2OD34's board of directors are considered experienced (4.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 18:36
End of Day Share Price 2024/12/16 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Insulet Corporation is covered by 58 analysts. 22 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anand VankawalaAvondale Partners
Jeffrey JohnsonBaird
null nullBaird